REG-Arix Bioscience PLC Full Year results now to be released on 25 April 2023

Arix BioscienceAnnouncement

19/04/2023 13:45

============

   Arix Bioscience PLC (ARIX)
   Full Year results now to be released on 25 April 2023

   19-Apr-2023 / 13:30 GMT/BST

   ════════════════════════════════════════════════════════════════════════════

                                         

                               Arix Bioscience plc

                                         

              Full Year results now to be released on 25 April 2023

   LONDON, 19 April 2023: Arix Bioscience  plc (“Arix” or the “Company”)  (LSE:
   ARIX), a  transatlantic  venture capital  company  focused on  investing  in
   breakthrough biotechnology companies, announces that, owing to a short delay
   in the audit process,  BDO, the company’s external  auditor, is not able  to
   complete the audit process of the  2022 financial results which were due  to
   be released on Thursday 20 April, 2023.

   The full year results will now be issued on Tuesday, 25 April 2023.

   The Board does not anticipate any material change to the unaudited net asset
   value per share for 31 December, 2022, as announced on 30 January, 2023.

   Analyst Briefing: 10:00am BST, Tuesday 25 April 2023

   Management will  host a  virtual briefing  for Analysts  at 10:00am  BST  on
   Tuesday 25 April. Analysts wishing to join should register their interest by
   contacting Powerscourt  on  1 arix@powerscourt-group.com  or on  +44 (0)  20
   7290 1050.

   Investor Presentation: 4:00pm BST, Tuesday 25 April 2023

   Management will  be hosting  a live  presentation and  Q&A session  via  the
   online platform, Investor Meet  Company, at 4:00pm BST  on Tuesday 25  April
   2023.

   The presentation  is  open  to  analysts  and  all  existing  and  potential
   shareholders. Questions can  be submitted  pre-event via  the Investor  Meet
   Company dashboard or at any time during the live presentation via the "Ask a
   Question" function.

   Investors  can   sign  up   to   Investor  Meet   Company  for   free   via:
    2 https://www.investormeetcompany.com/arix-bioscience-plc/register-investor

   Investors who already follow Arix on the Investor Meet Company platform will
   automatically receive an invitation to the event.
    

                                       ENDS 

    

   Enquiries

   For more information on Arix, please contact:

    

   Arix Bioscience plc

   +44 (0)20 7290 1050

   ir 3 @arixbioscience.com

    

   Powerscourt Group

   Sarah MacLeod, Ibrahim Khalil, Nick Johnson

   +44 (0)20 7250 1446

    4 arix@powerscourt-group.com

    

   About Arix Bioscience plc

   Arix Bioscience plc is  a transatlantic venture  capital company focused  on
   investing  in  breakthrough  biotechnology  companies  around   cutting-edge
   advances in life sciences.

    

   We collaborate  with  exceptional  entrepreneurs and  provide  the  capital,
   expertise, and networks to  help accelerate their  ideas into important  new
   treatments for patients.  As a  listed company, we  are able  to bring  this
   exciting growth  phase of  our industry  to a  broader range  of  investors.
    5 www.arixbioscience.com

    

    

   ════════════════════════════════════════════════════════════════════════════

   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ════════════════════════════════════════════════════════════════════════════

   ISIN:           GB00BD045071
   Category Code:  NOR
   TIDM:           ARIX
   LEI Code:       213800OVT3AHQCXNIX43
   OAM Categories: 3.1. Additional regulated information required to be
                   disclosed under the laws of a Member State
   Sequence No.:   238104
   EQS News ID:    1611817


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    6 fncls.ssp?fn=show_t_gif&application_id=1611817&application_name=news&site_id=refinitiv2

References

   Visible links
   1. mailto:arix@powerscourt-group.com
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=4d118b3300aa96332de7879ede8cb917&application_id=1611817&site_id=refinitiv2&application_name=news
   3. mailto:charlotte@arixbioscience.com
   4. mailto:arix@powerscourt-group.com
   5. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=889c637ce21c3a47a35c39202ebd9825&application_id=1611817&site_id=refinitiv2&application_name=news


============